Christine Chen

8.0k total citations · 1 hit paper
143 papers, 3.7k citations indexed

About

Christine Chen is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Christine Chen has authored 143 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Hematology, 73 papers in Molecular Biology and 60 papers in Oncology. Recurrent topics in Christine Chen's work include Multiple Myeloma Research and Treatments (88 papers), Protein Degradation and Inhibitors (41 papers) and Cancer Treatment and Pharmacology (36 papers). Christine Chen is often cited by papers focused on Multiple Myeloma Research and Treatments (88 papers), Protein Degradation and Inhibitors (41 papers) and Cancer Treatment and Pharmacology (36 papers). Christine Chen collaborates with scholars based in Canada, United States and Australia. Christine Chen's co-authors include Donna Reece, Suzanne Trudel, Jerome B. Zeldis, Robert Knight, Marta Olesnyckyj, Zhinuan Yu, Michael Wang, S. Vincent Rajkumar, Donna M. Weber and David S. Siegel and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christine Chen

129 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

2007 925 citations Donna M. Weber, Christine Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Chen Canada	28	2.3k	2.1k	1.5k	404	297	143	3.7k
Tanya M. Wildes United States	34	1.1k 0.5×	653 0.3×	1.6k 1.1×	250 0.6×	267 0.9×	225	3.6k
Liton Francisco United States	34	1.7k 0.8×	529 0.2×	1.1k 0.7×	301 0.7×	218 0.7×	109	3.9k
Saro H. Armenian United States	44	968 0.4×	536 0.3×	1.7k 1.2×	260 0.6×	513 1.7×	238	5.9k
Yusuf Yazıcı United States	43	1.5k 0.7×	576 0.3×	280 0.2×	509 1.3×	619 2.1×	237	6.1k
Gunnar Birgegård Sweden	33	3.1k 1.4×	1.2k 0.6×	557 0.4×	2.6k 6.5×	53 0.2×	121	4.8k
H. K. Ronday Netherlands	33	1.3k 0.6×	389 0.2×	291 0.2×	550 1.4×	488 1.6×	63	4.4k
Roland Laan Netherlands	38	444 0.2×	1.1k 0.5×	1.2k 0.8×	304 0.8×	447 1.5×	93	5.6k
Caroline Laverdière Canada	35	511 0.2×	687 0.3×	948 0.6×	214 0.5×	203 0.7×	181	4.3k
María A. López-Olivo United States	34	673 0.3×	277 0.1×	974 0.6×	421 1.0×	339 1.1×	134	4.4k
Cornelia F Allaart Netherlands	46	2.1k 0.9×	561 0.3×	438 0.3×	1.3k 3.3×	896 3.0×	189	7.3k

Countries citing papers authored by Christine Chen

Since Specialization

Citations

This map shows the geographic impact of Christine Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Chen more than expected).

Fields of papers citing papers by Christine Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Chen. The network helps show where Christine Chen may publish in the future.

Co-authorship network of co-authors of Christine Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Chen. A scholar is included among the top collaborators of Christine Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Chen. Christine Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Arjun, et al.. (2025). Artificial Intelligence-assisted Translation and Interpretation for Communication With Patients Who Have Language Barriers: A Systematic Review. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3643–A3643.

Chen, Christine, et al.. (2025). Bridging language gaps in healthcare: a systematic review of the practical implementation of neural machine translation technologies in clinical settings. Journal of the American Medical Informatics Association. 32(11). 1756–1766.

Mirshahvalad, Seyed Ali, Andrés Kohan, Claudia Ortega, et al.. (2025). Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy. Scientific Reports. 15(1). 39540–39540.

Sabatini, Peter, Tong Zhang, Harriet Feilotter, et al.. (2025). Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status. American Journal of Clinical Pathology. 164(3). 474–483.

Lajkosz, Katherine, Esther Masih‐Khan, Donna Reece, et al.. (2023). The Impact of CD34+ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 23(11). 850–856. 2 indexed citations

Bell, Jennifer, et al.. (2023). Mitigating inequity: ethically prioritizing patients for CAR T-cell therapy. Blood. 142(15). 1263–1270. 15 indexed citations

Mayo, Samantha, et al.. (2021). Computerized cognitive training in post-treatment hematological cancer survivors: a feasibility study. Pilot and Feasibility Studies. 7(1). 36–36. 12 indexed citations

Chen, Christine & Wen‐Chung Lee. (2018). Attributing diseases to multiple pathways: a causal-pie modeling approach. Clinical Epidemiology. Volume 10. 489–497. 8 indexed citations

Reece, Donna, Young Trieu, Esther Masih‐Khan, et al.. (2016). Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 16(7). 387–394. 12 indexed citations

10.

Scher, Eli D., Paul B. Romesser, Christine Chen, et al.. (2015). Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience. Oral Oncology. 51(7). 709–715. 28 indexed citations

11.

Sun, Haowei, Eshetu G. Atenafu, Donna Reece, et al.. (2014). Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone. Leukemia & lymphoma. 56(2). 407–414. 5 indexed citations

12.

Reece, Donna, Suzanne Trudel, Norman Franke, et al.. (2013). Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival. Leukemia & lymphoma. 55(10). 2284–2289. 14 indexed citations

13.

White, Darrell, Nizar J. Bahlis, Andrew R. Belch, et al.. (2012). Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial. Clinical Lymphoma Myeloma & Leukemia. 13(1). 19–24. 2 indexed citations

14.

Jiménez‐Zepeda, Víctor H., Donna Reece, Suzanne Trudel, et al.. (2012). Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma. Leukemia & lymphoma. 54(3). 555–560. 10 indexed citations

15.

Jiménez‐Zepeda, Víctor H., Suzanne Trudel, Andrew Winter, et al.. (2012). Autologous stem cell transplant for light chain deposition disease: Incorporating bortezomib to the induction therapy. American Journal of Hematology. 87(8). 822–823. 11 indexed citations

16.

Dimopoulos, Meletios Α., Christine Chen, Efstathios Kastritis, Maria Gavriatopoulou, & Steven P. Treon. (2010). Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 10(2). 110–117. 17 indexed citations

17.

Chen, Christine, Donna Reece, David S. Siegel, et al.. (2009). Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma. British Journal of Haematology. 146(2). 164–170. 62 indexed citations

18.

Wang, Michael, Meletios Α. Dimopoulos, Christine Chen, et al.. (2008). Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure. Blood. 112(12). 4445–4451. 135 indexed citations

19.

Reece, Donna, Christine Chen, Suzanne Trudel, et al.. (2008). Phase I-II Trial of Bortezomib Plus Oral Cyclophosphamide and Prednisone in Relapsed and Refractory Multiple Myeloma. Journal of Clinical Oncology. 26(29). 4777–4783. 72 indexed citations

20.

Chen, Christine, Michael Crump, Richard Tsang, A. Keith Stewart, & Armand Keating. (2001). Autotransplants for histologically transformed follicular non‐Hodgkin's lymphoma. British Journal of Haematology. 113(1). 202–208. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact